Arrowhead Pharmaceuticals, Inc.
|
Website:
arrowheadpharma.com |
|
|
Headquarters:
Pasadena, CA, US |
|
|
Company Type:
Small Business (1-10M TTM Revenue) |
Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing.
| Site | Badges | |
|---|---|---|
| Arrowhead Pharmaceuticals, Inc. 465 Science Drive Madison, WI, 53711 United States | ||
| Arrowhead Pharmaceuticals, Inc. 225 South Lake Avenue Pasadena, CA, 91101 United States | ||
| Arrowhead Pharmaceuticals, Inc. 225 South Lake Avenue Pasadena, CA, 91101 United States | ||
Get started
To request access, simply fill out the form below and we will contact you.